TWERENBOLD, R., P. BADERTSCHER, J. BOEDDINGHAUS, T. NESTELBERGER, K. WILDI, C. PUELACHER, Z. SABTI, M.R. GIMENEZ, S. TSCHIRKY, J.D. de LAVALLAZ, N. KOZHUHAROV, L. SAZGARY, D. MUELLER, T. BREIDTHARDT, I. STREBEL, D.F. WIDMER, S. SHRESTHA, O. MIRO, F.J. MARTIN-SANCHEZ, B. MORAWIEC, Jiří PAŘENICA, N. GEIGY, D.I. KELLER, K. RENTSCH, A. von ECKARDSTEIN, S. OSSWALD, T. REICHLIN and C. MUELLER. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction. Circulation. Philadelphia: Lippincott Williams Wilkins, 2018, vol. 137, No 5, p. 436-451. ISSN 0009-7322. Available from: https://dx.doi.org/10.1161/CIRCULATIONAHA.117.028901.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction
Authors TWERENBOLD, R. (756 Switzerland), P. BADERTSCHER (756 Switzerland), J. BOEDDINGHAUS (756 Switzerland), T. NESTELBERGER (756 Switzerland), K. WILDI (756 Switzerland), C. PUELACHER (756 Switzerland), Z. SABTI (756 Switzerland), M.R. GIMENEZ (756 Switzerland), S. TSCHIRKY (756 Switzerland), J.D. de LAVALLAZ (756 Switzerland), N. KOZHUHAROV (756 Switzerland), L. SAZGARY (756 Switzerland), D. MUELLER (756 Switzerland), T. BREIDTHARDT (756 Switzerland), I. STREBEL (756 Switzerland), D.F. WIDMER (756 Switzerland), S. SHRESTHA (756 Switzerland), O. MIRO (724 Spain), F.J. MARTIN-SANCHEZ (724 Spain), B. MORAWIEC (616 Poland), Jiří PAŘENICA (203 Czech Republic, belonging to the institution), N. GEIGY (756 Switzerland), D.I. KELLER (756 Switzerland), K. RENTSCH (756 Switzerland), A. von ECKARDSTEIN (756 Switzerland), S. OSSWALD (756 Switzerland), T. REICHLIN (756 Switzerland) and C. MUELLER (756 Switzerland, guarantor).
Edition Circulation, Philadelphia, Lippincott Williams Wilkins, 2018, 0009-7322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 23.054
RIV identification code RIV/00216224:14110/18:00103658
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028901
UT WoS 000423565200005
Keywords in English 0/1-hour algorithm; chronic kidney disease; diagnosis of acute myocardial infarction; high-sensitivity cardiac troponin; renal dysfunction
Tags 14110211, EL OK, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 11/2/2019 16:08.
Abstract
Background: The European Society of Cardiology recommends a 0/1-hour algorithm for rapid rule-out and rule-in of non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin (hs-cTn) concentrations irrespective of renal function. Because patients with renal dysfunction (RD) frequently present with increased hs-cTn concentrations even in the absence of non-ST-segment elevation myocardial infarction, concern has been raised regarding the performance of the 0/1-hour algorithm in RD. Methods: In a prospective multicenter diagnostic study enrolling unselected patients presenting with suspected non-ST-segment elevation myocardial infarction to the emergency department, we assessed the diagnostic performance of the European Society of Cardiology 0/1-hour algorithm using hs-cTnT and hs-cTnI in patients with RD, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2), and compared it to patients with normal renal function. The final diagnosis was centrally adjudicated by 2 independent cardiologists using all available information, including cardiac imaging. Safety was quantified as sensitivity in the rule-out zone, accuracy as the specificity in the rule-in zone, and efficacy as the proportion of the overall cohort assigned to either rule-out or rule-in based on the 0- and 1-hour sample. Results: Among 3254 patients, RD was present in 487 patients (15%). The prevalence of non-ST-segment elevation myocardial infarction was substantially higher in patients with RD compared with patients with normal renal function (31% versus 13%, P<0.001). Using hs-cTnT, patients with RD had comparable sensitivity of rule-out (100.0% [95% confidence interval {CI}, 97.6-100.0] versus 99.2% [95% CI, 97.6-99.8]; P=0.559), lower specificity of rule-in (88.7% [95% CI, 84.8-91.9] versus 96.5% [95% CI, 95.7-97.2]; P<0.001), and lower overall efficacy (51% versus 81%, P<0.001), mainly driven by a much lower percentage of patients eligible for rule-out (18% versus 68%, P<0.001) compared with patients with normal renal function. Using hs-cTnI, patients with RD had comparable sensitivity of rule-out (98.6% [95% CI, 95.0-99.8] versus 98.5% [95% CI, 96.5-99.5]; P=1.0), lower specificity of rule-in (84.4% [95% CI, 79.9-88.3] versus 91.7% [95% CI, 90.5-92.9]; P<0.001), and lower overall efficacy (54% versus 76%, P<0.001; proportion ruled out, 18% versus 58%, P<0.001) compared with patients with normal renal function. Conclusions: In patients with RD, the safety of the European Society of Cardiology 0/1-hour algorithm is high, but specificity of rule-in and overall efficacy are decreased. Modifications of the rule-in and rule-out thresholds did not improve the safety or overall efficacy of the 0/1-hour algorithm. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT00470587.
PrintDisplayed: 23/5/2024 04:35